Acute generalized exanthematous pustulosis: clinical features, differential diagnosis, and management
R Parisi, H Shah, AA Navarini, B Muehleisen… - American Journal of …, 2023 - Springer
Acute generalized exanthematous pustulosis (AGEP) is a rare, acute, severe cutaneous
adverse reaction mainly attributed to drugs, although other triggers, including infections …
adverse reaction mainly attributed to drugs, although other triggers, including infections …
Severe cutaneous adverse reactions
SI Hung, M Mockenhaupt, KG Blumenthal… - Nature Reviews …, 2024 - nature.com
Severe cutaneous adverse reactions (SCARs), which include Stevens–Johnson syndrome
and toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (also …
and toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (also …
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review
NFB Rubaian, AA Aljalfan… - Journal of Family and …, 2023 - journals.lww.com
Despite the numerous reports of cutaneous manifestations associated with vaccines for
coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and …
coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and …
Helper T cell subsets: Development, function and clinical role in hypersensitivity reactions in the modern perspective
Helper T cells are traditionally classified into T helper 1 (TH 1) and T helper 2 (TH 2). The
more recent discoveries of T helper 17 (TH 17), follicular helper T cells (T FH) and regulatory …
more recent discoveries of T helper 17 (TH 17), follicular helper T cells (T FH) and regulatory …
Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?
M Kasap Cuceoglu, O Basaran, O Soyer… - Journal of Clinical …, 2022 - mdpi.com
Juvenile idiopathic arthritis (JIA) is one of the most frequent diseases in the practice of
pediatric rheumatology. JIA treatments have been modified and improved with the use of …
pediatric rheumatology. JIA treatments have been modified and improved with the use of …
Determine and remove the drug trigger, usually antibiotics, that causes acute generalised exanthematous pustulosis
ES Kim, C Kang - 2024 - Springer
A wide range of drugs has been associated with the development of acute generalised
exanthematous pustulosis (AGEP). Although AGEP is rare and typically self-limiting once the …
exanthematous pustulosis (AGEP). Although AGEP is rare and typically self-limiting once the …
[引用][C] Hydroxychloroquine-induced acute generalized exanthematous pustulosis (AGEP) treated with secukinumab.
Y Wang, Y Liu, C Feng, M Wang, Q Wang… - Journal of the …, 2024 - europepmc.org
Hydroxychloroquine-induced acute generalized exanthematous pustulosis (AGEP) treated with
secukinumab. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
secukinumab. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …